-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, SkGYqth5ATVo/Su9J85zS3fKWXmtZDXKIHmDQs3J44S5qDLr0Omu5tTKprySMOvS pCRSMtZZL/tMtEotxSEGoQ== 0000357235-07-000152.txt : 20070214 0000357235-07-000152.hdr.sgml : 20070214 20070214090515 ACCESSION NUMBER: 0000357235-07-000152 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20070214 DATE AS OF CHANGE: 20070214 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: PharmaNet Development Group Inc CENTRAL INDEX KEY: 0001089542 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 592407464 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-61063 FILM NUMBER: 07613913 BUSINESS ADDRESS: STREET 1: 504 CARNEGIE CENTER CITY: PRINCETON STATE: NJ ZIP: 08540-6242 BUSINESS PHONE: 609-951-6800 MAIL ADDRESS: STREET 1: 504 CARNEGIE CENTER CITY: PRINCETON STATE: NJ ZIP: 08540-6242 FORMER COMPANY: FORMER CONFORMED NAME: SFBC INTERNATIONAL INC DATE OF NAME CHANGE: 19990625 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: BRANDYWINE ASSET MANAGEMENT LLC CENTRAL INDEX KEY: 0000829108 STANDARD INDUSTRIAL CLASSIFICATION: UNKNOWN SIC - 0000 [0000] IRS NUMBER: 510294965 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A BUSINESS ADDRESS: STREET 1: THREE CHRISTINA CENTRE STREET 2: 201 N WALNUT ST STE 1200 CITY: WILIMINGTON STATE: DE ZIP: 19801 BUSINESS PHONE: 3026546162 MAIL ADDRESS: STREET 1: THREE CHRISTINA CENTRE SUITE 1200 STREET 2: 201 NORTH WALNUT STREET CITY: WILMINGTON STATE: DE ZIP: 19801 FORMER COMPANY: FORMER CONFORMED NAME: BRANDYWINE ASSET MANAGEMENT INC DATE OF NAME CHANGE: 19940214 SC 13G/A 1 pdgiamendment.txt PHARMANET DEVELOPMENT GROUP Securities and Exchange Commission Washington, D. C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No. 2) PharmaNet Development Group Common Stock CUSIP Number 717148100 Date of Event Which Requires Filing of this Statement: December 31, 2006 Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [ X ] Rule 13d-1(b) [ ] Rule 13d-1(c) [ ] Rule 13d-1(d) CUSIP No. 717148100 1) Name of reporting person: Brandywine Global Investment Management, LLC Tax Identification No.: 51-0294065 2) Check the appropriate box if a member of a group: a) n/a b) n/a 3) SEC use only 4) Place of organization: Delaware Number of shares beneficially owned by each reporting person with: 5) Sole voting power: 1,458,657 6) Shared voting power: - 0 - 7) Sole dispositive power: - 0 - 8) Shared dispositive power: 1,467,472 9) Aggregate amount beneficially owned by each reporting person: 1,467,472 10) Check if the aggregate amount in row (9) excludes certain shares n/a 11) Percent of class represented by amount in row (9): 7.97% 12) Type of reporting person: IA, OO ___________________________________________________________________________ Item 1a) Name of issuer: PharmaNet Development Group Item 1b) Address of issuers principal executive offices: 504 Carnegie Center Princeton NJ 08540 Item 2a) Name of person filing: Brandywine Global Investment Management, LLC Item 2b) Address of principal business office: 2929 Arch Street 8th Floor Philadelphia, PA 19104 Item 2c) Citizenship: Delaware Limited Liability Company Item 2d) Title of class of securities: Common Stock Item 2e) CUSIP number: 717148100 Item 3) If this statement is filed pursuant to Rule 13d-1(b), or 13d-2(b), check whether the person filing is a: (a)[ ]Broker or dealer under Section 15 of the Act. (b)[ ]Bank as defined in Section 3(a) (6) of the Act. (c)[ ]Insurance Company as defined in Section 3(a) (6) of the Act. (d)[ ]Investment Company registered under Section 8 of the Investment Company Act. (e)[X]Investment Adviser registered under Section 203 of the Investment Advisers Act of 1940. (f)[ ]Employee Benefit Plan, Pension Fund which is subject to ERISA of 1974 or Endowment Fund; see 240.13d-1(b)(ii)(F). (g)[ ] Parent holding company, in accordance with 240.13d-1(b)(ii)(G). (h)[ ] Group, in accordance with 240.13d-1(b)(1)(ii)(H). Item 4) Ownership: (a) Amount beneficially owned: 1,467,472 (b) Percent of Class: 7.97% (c) Number of shares as to which such person has: (i) sole power to vote or to direct the vote: 1,458,657 (ii) shared power to vote or to direct the vote: - 0 - (iii) sole power to dispose or to direct the disposition of: - 0 - (iv) shared power to dispose or to direct the disposition of: 1,467,472 Item 5) Ownership of Five Percent or less of a class: n/a Item 6) Ownership of more than Five Percent on behalf of another person: No single account owns more than 5% of the shares outstanding. Item 7) Identification and classification of the subsidiary which acquired the security being reported on by the parent holding company: n/a Item 8) Identification and classification of members of the group: n/a Item 9) Notice of dissolution of group: n/a Item 10) Certification: By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect. Signature ----------- After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. ------------------------------- Date - February 14, 2007 Brandywine Global Investment Management, LLC By _________________________________________________ /s/ Mark Glassman Chief Accounting Officer -----END PRIVACY-ENHANCED MESSAGE-----